Opis

• Tytuł:
  The Review of pharmacological treatment registered for obesity in Poland
• Twórca:
  Wyrwał, Julia;
  Nowak, Karolina;
  Olejarz, Zuzanna;
  Drygała, Zuzanna;
  Zielińska, Zuzanna;
  Słowik, Magdalena;
  Nieć, Maria;
  Gierlach, Katarzyna;
  Krasuska, Martyna
• Opis:
  Introduction: Obesity is a persistent chronic condition. It is associated with an increased riskof premature death and the development of accompanying diseases. According to statisticaldata, half of the population struggles with excessive body weight, with one in five Polesbeing obese. [2]Aim: Our study aimed to evaluate the current literature on pharmacotherapy for obesityavailable in Poland using the PubMed database. We emphasize the crucial importance of anindividualized patient approach to attain therapeutic success, aligning with the latestguidelines and scientific research.A brief description of the state of knowledge: In Poland, we have three registeredmedications intended for the treatment of obesity: naltrexone/bupropion, liraglutide, andorlistat. It's crucial that they assist in weight reduction, hence they should be used alongsidea proper diet and physical activity, not as the sole form of treatment. Using them assists inachieving therapeutic targets determined in partnership with the patient, and lowers levels ofparticular indicators linked to chronic inflammation and arterial issues. Moreover, theydiminish the chances of complications and early mortality due to the advancement of thecondition.Summary: Obesity is a serious condition, and there should be no fear in incorporatingpharmacotherapy in patients with it. It is incredibly important to effectively treat this diseaseand take proactive health measures, even at the stage of overweight, considering it as aprecursor to obesity.
• Dostępność obiektu:
  Dostęp otwarty
• Prawa: https://creativecommons.org/licenses/by-nc-sa/4.0 ;
  Prawa autorskie (c) 2024 Julia Wyrwał, Karolina Nowak, Zuzanna Olejarz, Zuzanna Drygała, Zuzanna Zielińska, Magdalena Słowik, Karolina Nowak, Maria Nieć, Katarzyna Gierlach, Martyna Krasuska
• Data:
  2024.02.01
• Typ:
  info:eu-repo/semantics/article;
  info:eu-repo/semantics/publishedVersion
• Język:
  angielski
• Źródło:
  Journal of Education, Health and Sport; Vol. 56 (2024); 54-67;
  Journal of Education, Health and Sport; Tom 56 (2024); 54-67;
  2391-8306
• Format:
  application/pdf
• Wydawca:
  Nicolaus Copernicus University, Toruń, Poland
• Relacja: https://apcz.umk.pl/JEHS/article/view/47954/37542
• Temat i słowa kluczowe:
  Obesity;
  Orlistat;
  Bupropion;
  Naltrexone;
  Liraglutide
• Identyfikator: https://apcz.umk.pl/JEHS/article/view/47954
• Dostawca danych:
  Akademicka Platforma Czasopism
• Czy mogę z tego obiektu skorzystać?:
  poproś o pozwolenie
• Rodzaj zawartości:
  teksty